Samuel Z. Goldhaber, MD, explores the role that betrixaban can play in the prevention of VTE and stroke in medically ill patients.

Presented at NATF’s “Stopping the VTE Epidemic: An Innovative, Cutting Edge, and State-of-the-Art Action Plan” program on April 19, 2018.